Diebold Nixdorf Leaders to Participate in Upcoming Investor Conferences
Get Alerts DBD Hot Sheet
Join SI Premium – FREE
HUDSON, Ohio, May 12, 2022 /PRNewswire/ -- Diebold Nixdorf (NYSE: DBD), a global leader in driving connected commerce across the banking and retail industries, announced today that Octavio Marquez, chief executive officer, and Jeffrey Rutherford, chief financial officer, will speak at two upcoming investor conferences.
On Monday, May 23 at 3:10 p.m. ET, Marquez will speak at the 50th Annual J.P. Morgan Global Technology, Media and Communications Conference in a fireside chat. Audio for the session can be found at https://jpmorgan.metameetings.net/events/tmc22/sessions/42079-diebold-nixdorf/webcast. Additionally, Rutherford will speak at the Barclays Leveraged Finance Conference on Tuesday, May 24 at 4:00 p.m. ET, in a fireside chat. This session can be accessed here.
Both presentations will be available on Diebold Nixdorf's investor relations website at Events & Presentations.
About Diebold Nixdorf
Diebold Nixdorf, Incorporated (NYSE: DBD) is a world leader in enabling connected commerce. We automate, digitize and transform the way people bank and shop. As a partner to the majority of the world's top 100 financial institutions and top 25 global retailers, our integrated solutions connect digital and physical channels conveniently, securely and efficiently for millions of consumers each day. The company has a presence in more than 100 countries with approximately 22,000 employees worldwide. Visit www.DieboldNixdorf.com for more information.
LinkedIn: www.linkedin.com/company/diebold Twitter: twitter.com/dieboldnixdorfFacebook: www.facebook.com/DieboldNixdorfYouTube: www.youtube.com/dieboldnixdorf
DN-F
View original content to download multimedia:https://www.prnewswire.com/news-releases/diebold-nixdorf-leaders-to-participate-in-upcoming-investor-conferences-301546183.html
SOURCE Diebold Nixdorf, Incorporated
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ivonescimab Versus Pembrolizumab in First-Line PD-L1-Positive NSCLC: Positive Overall Survival Results from HARMONi-2 Presented at WCLC 2026
- CLARITY Act Vote Lands September 15, 6 Best Crypto Presales Ahead of Crypto’s Big Washington Test
- Doginal Dogs Reports Record Turnout at DDNYC 2026, Its Largest Event to Date
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
JPMorgan, Barclays, TwitterSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share